- Home
- FHTX vs QSI Comparison
FHTX vs QSI Comparison
Compare FHTX & QSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FHTX | QSI |
|---|---|---|
| Founded | 2015 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 173.4M | 165.6M |
| IPO Year | 2020 | 2020 |
Fundamental Metrics
Financial Performance| Metric | FHTX | QSI |
|---|---|---|
| Price | $1.92 | $1.26 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 10 | 3 |
| Target Price | ★ $6.00 | $2.28 |
| AVG Volume (30 Days) | 1.0M | ★ 5.1M |
| Earning Date | 11-04-2026 | 11-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 25.32 | ★ 28.17 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $30,909,000.00 | $2,436,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $15.98 | $406.32 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 36.75 | N/A |
| 52 Week Low | $1.79 | $0.69 |
| 52 Week High | $7.61 | $3.10 |
Technical Indicators
Market Signals| Indicator | FHTX | QSI |
|---|---|---|
| Relative Strength Index (RSI) | 15.14 | 67.50 |
| Support Level | N/A | $0.81 |
| Resistance Level | $5.35 | $1.32 |
| Average True Range (ATR) | 0.30 | 0.12 |
| MACD | -0.16 | 0.05 |
| Stochastic Oscillator | 5.53 | 65.19 |
Price Performance
Historical ComparisonAbout FHTX Foghorn Therapeutics Inc.
Foghorn Therapeutics Inc is a clinical stage, precision therapeutics biotechnology company focused on pioneering a new class of medicines that treat serious diseases by correcting abnormal gene expression through selectively targeting the chromatin regulatory system. Its proprietary platform is designed to provide an integrated, mechanistic understanding of interactions within the chromatin regulatory system, supporting the identification and validation of potential therapeutic targets. The company's flagship program is FHD-909.
About QSI Quantum-Si Incorporated
Quantum-Si Inc is a life sciences company focused on proteomics research and analytical technologies. It develops single-molecule detection platforms designed to enable next-generation protein sequencing (NGPS) and large-scale protein analysis. Its technology supports massively parallel sequencing of proteins and can also be applied to the study of nucleic acids, providing tools for researchers and clinical applications in molecular analysis. The company's revenue is derived from sales of products and services.